Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism
Authors:
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 85 (2) , 436-440
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The modern management of hirsutismReviews in Gynaecological Practice, 2004
- Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetateJournal of Thrombosis and Haemostasis, 2004
- An observational study of Yasmin® in the management of women with polycystic ovary syndromeBMJ Sexual & Reproductive Health, 2004
- Drospirenone for the Treatment of Hirsute Women with Polycystic Ovary Syndrome: A Clinical, Endocrinological, Metabolic Pilot StudyThe Journal of Clinical Endocrinology & Metabolism, 2004
- Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic Hyperandrogenism: Opposite Effects on Adipocytokines and Body AdiposityThe Journal of Clinical Endocrinology & Metabolism, 2004
- Thromboembolism associated with the new contraceptive YasminBMJ, 2003
- Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?Human Reproduction, 2001
- A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of HirsutismThe Journal of Clinical Endocrinology & Metabolism, 1999
- A comparative study of Aldactone® and Diane® in the treatment of hirsutismThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Hirsutism: Implications, etiology, and managementAmerican Journal of Obstetrics and Gynecology, 1981